Small bowel capsule endoscopy (SBCE) is a key modality for evaluating obscure gastrointestinal bleeding, iron-deficiency anemia, and suspected small bowel disease. The dual-camera MiroCam capsule, increasingly used in the United Arab Emirates (UAE), provides enhanced mucosal visualization. Real-world dataOK from the region remain limited. This study evaluates the performance and diagnostic patterns of SBCE using the dual-camera MiroCam system in routine clinical practice.

A retrospective review of 463 consecutive SBCE examinations performed in a UAE tertiary center was conducted. Variables collected included demographics, completion rate, visualization quality, capsule retention, and predefined diagnostic categories (normal, inflammatory, ulcerative, vascular, structural). Descriptive statistics were generated.

A total of 463 patients were included (mean age 48.7 years, 55% female).Technical performance was high:

• Completion rate: 92%

• Good/fair visualization: 96%

• Capsule retention: 2.6%

Diagnostic patterns (n=463):

• Normal studies: 32.4% (150/463)

• Inflammatory lesions (mild–severe): 36.1% (167/463)

• Vascular lesions: 16.8% (78/463)

• Ulcerative lesions: 11.2% (52/463)

• Structural abnormalities: 1.9% (9/463)

Inflammatory and vascular findings accounted for the majority of abnormal examinations. The dual-camera system provided high-quality visualization throughout the small bowel, supporting detection of both subtle and extensive lesions.

In this real-world UAE cohort, dual-camera MiroCam SBCE demonstrated excellent completion and visualization rates with a low retention rate. Clinically relevant abnormalities were identified in over two-thirds of abnormal studies. These findings support the routine clinical use of dual-camera MiroCam SBCE for comprehensive small bowel evaluation in the UAE.